-
Amalia Enriquez-De-Salamanca
IOBA-University of Valladolid, Valladolid, Spain
CIBER-BBN (Biomedical Research Networking Center in Bioengeneering, Biomaterials and Nanomedicine), Valladolid, Spain
-
Lidia Cocho
IOBA-University of Valladolid, Valladolid, Spain
-
Itziar Fernández
IOBA-University of Valladolid, Valladolid, Spain
CIBER-BBN (Biomedical Research Networking Center in Bioengeneering, Biomaterials and Nanomedicine), Valladolid, Spain
-
Dolores Caballero
Hematology Service, University Hospital -University of Salamanca, Salamanca, Spain
IBSAL (Instituto Biosanitario de Salamanca), Salamanca, Spain
-
Lucia López-Corral
Hematology Service, University Hospital -University of Salamanca, Salamanca, Spain
IBSAL (Instituto Biosanitario de Salamanca), Salamanca, Spain
-
Verónica Martínez-Tottil
IOBA-University of Valladolid, Valladolid, Spain
-
Maria-Jesus Gonzalez
IOBA-University of Valladolid, Valladolid, Spain
CIBER-BBN (Biomedical Research Networking Center in Bioengeneering, Biomaterials and Nanomedicine), Valladolid, Spain
-
Carmen García-Vázquez
IOBA-University of Valladolid, Valladolid, Spain
-
Michael E Stern
Biological Sciences, Allergan Inc, Irvine, CA
-
Margarita Calonge
IOBA-University of Valladolid, Valladolid, Spain
CIBER-BBN (Biomedical Research Networking Center in Bioengeneering, Biomaterials and Nanomedicine), Valladolid, Spain